UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549


                                  SCHEDULE 13D
                                 (RULE 13D-101)

             INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
            TO RULE 13D-1(A) AND AMENDMENTS THERETO FILED PURSUANT TO
                                  RULE 13D-2(A)

                                (Amendment No. )

                          SOMANTA PHARMACEUTICALS, INC.
                                (Name of Issuer)

                         COMMON STOCK, PAR VALUE $0.001
                         (Title of Class of Securities)

                                   834446 10 6
                                 (CUSIP Number)

                               Steven H. Rouhandeh
                            SCO Capital Partners LLC
                     1285 Avenue of the Americas, 35th Floor
                            New York, New York 10019
                                 (212) 554-4158
                  (Name, Address and Telephone Number of Person
                Authorized to Receive Notices and Communications)

                                January 31, 2006
             (Date of Event Which Requires Filing of This Statement)


     If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box [ ].


                         (Continued on following pages)

                               (Page 1 of 9 Pages)






CUSIP NO. 834446 10 6                 13D                      PAGE 2 OF 9 PAGES
--------------------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
   IRS IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
   SCO Capital Partners LLC
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                    (a) [ ]
                                                                        (b) [X]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. SOURCE OF FUNDS*
   OO
--------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
   TO ITEM 2(d) or 2(e)                                                   [ ]
--------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
   Delaware
--------------------------------------------------------------------------------
  NUMBER OF             7. SOLE VOTING POWER           14,825,251
   SHARES              ---------------------------------------------------------
BENEFICIALLY            8. SHARED VOTING POWER                  0
  OWNED BY             ---------------------------------------------------------
    EACH                9. SOLE DISPOSITIVE POWER      14,825,251
  REPORTING            ---------------------------------------------------------
PERSON WITH            10. SHARED DISPOSITIVE POWER             0
--------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    14,825,251
--------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
    CERTAIN SHARES*                                                       [ ]
--------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    51.0%
--------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON*
    PN
--------------------------------------------------------------------------------
                      *SEE INSTRUCTIONS BEFORE FILLING OUT!

                                        2





CUSIP NO. 834446 10 6                 13D                      PAGE 3 OF 9 PAGES
--------------------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
   IRS IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
   SCO Securities LLC
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                     (a) [ ]
                                                                         (b) [X]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. SOURCE OF FUNDS*
   OO
--------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
   TO ITEM 2(d) or 2(e)                                                   [ ]
--------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
   Delaware
--------------------------------------------------------------------------------
  NUMBER OF             7. SOLE VOTING POWER                    0
   SHARES              ---------------------------------------------------------
BENEFICIALLY            8. SHARED VOTING POWER                  0
  OWNED BY             ---------------------------------------------------------
    EACH                9. SOLE DISPOSITIVE POWER               0
  REPORTING            ---------------------------------------------------------
 PERSON WITH           10. SHARED DISPOSITIVE POWER             0
--------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    0
--------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
    CERTAIN SHARES*                                                       [ ]
--------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0%
--------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON*
    BD
--------------------------------------------------------------------------------
                      *SEE INSTRUCTIONS BEFORE FILLING OUT!

                                        3





CUSIP NO. 834446 10 6                  13D                     PAGE 4 OF 9 PAGES
--------------------------------------------------------------------------------
1. NAMES OF REPORTING PERSONS
   IRS IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
   Steven H. Rouhandeh
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                     (a) [ ]
                                                                         (b) [X]
--------------------------------------------------------------------------------
3. SEC USE ONLY
--------------------------------------------------------------------------------
4. SOURCE OF FUNDS*
   OO
--------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
   TO ITEM 2(d) or 2(e)                                                   [ ]
--------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
   United States
--------------------------------------------------------------------------------
  NUMBER OF             7. SOLE VOTING POWER           14,825,251
   SHARES              ---------------------------------------------------------
BENEFICIALLY            8. SHARED VOTING POWER          1,061,775
  OWNED BY              --------------------------------------------------------
    EACH                9. SOLE DISPOSITIVE POWER      14,825,251
  REPORTING            ---------------------------------------------------------
 PERSON WITH           10. SHARED DISPOSITIVE POWER     1,061,775
--------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    15,887,026
--------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
    CERTAIN SHARES*                                                       [ ]
--------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    52.7%
--------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON*
    IN
--------------------------------------------------------------------------------
                      *SEE INSTRUCTIONS BEFORE FILLING OUT!


                                       4






ITEM 1.  SECURITY AND ISSUER.

This Schedule 13D ("Schedule 13D") is being filed with respect to the common
stock, par value $.001 per share (the "Common Stock") of Somanta
Pharmaceuticals, Inc., a Delaware corporation (the "Company"). The principal
executive offices of the Company are located at 19200 Von Karman Avenue, Suite
400, Irvine, CA 92612.

This Schedule 13D is being filed pursuant to Section 13(d) of the Securities
Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder (the "Exchange Act").

ITEM 2.  IDENTITY AND BACKGROUND.

(a) This Schedule 13D is filed by (i) Steven H. Rouhandeh ("Mr. Rouhandeh"),
(ii) SCO Capital Partners LLC, a limited liability company organized under the
laws of the State of Delaware ("SCO"), and (iii) SCO Securities LLC, a limited
liability company organized under the laws of the State of Delaware ("SCO
Securities"). Mr. Rouhandeh, SCO and SCO Securities are collectively referred to
herein as the "Reporting Persons."

(b) The Reporting Persons' business address is 1285 Avenue of the Americas, 35th
Floor, New York, New York 10019.

(c) The principal business of Mr. Rouhandeh is to serve as the Chairman and sole
member of SCO and sole member of the entity that serves as sole member of SCO
Securities. The principal business of SCO is to invest in biotechnology
companies. The principal business of SCO Securities is to provide certain
broker-dealer services to biotechnology companies.

(d) During the last five years, none of the Reporting Persons have been
convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors).

(e) During the last five years, none of the Reporting Persons have been a party
to a civil proceeding of a judicial or administrative body of competent
jurisdiction that resulted in a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to, Federal or
State securities laws or finding any violation with respect to such laws.

(f) Mr. Rouhandeh is a United States citizen. SCO and SCO Securities are each a
limited liability company organized under the laws of the State of Delaware.

ITEM 3.  SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

SCO was previously the holder of common stock of Somanta Incorporated, a
privately-held Delaware corporation ("Somanta"). On January 31, 2006, pursuant
to a merger transaction between the Company and Somanta (the "Merger"), Somanta
became a wholly-owned subsidiary of the Company and SCO received 6,016,725
shares of the Company's Common Stock in exchange for the shares of Somanta
common stock then held by SCO. In addition, pursuant to the Merger, each of the
Sophie C. Rouhandeh Trust (the "SR Trust"), the SHR Family Trust (the "SHR
Trust") and the Chloe H. Rouhandeh Trust (the "CR Trust" and, together with the
SR Trust and the SHR Trust, the "Trusts"), with respect to each of which Mr.
Rouhandeh, serves as a trustee, received 353,925 shares of Common Stock in
exchange for the shares of Somanta common stock then held by each of them
(1,061,775 shares of Common Stock in the


                                        5




aggregate held by the three Trusts). As a trustee of the Trusts, Mr. Rouhandeh
has shared voting power and shared investment power with respect to these
shares, but disclaims any beneficial ownership thereof.

On January 31, 2006 upon closing of a private placement financing pursuant to
which SCO Securities acted as placement agent (the "Private Placement"), the
Company issued to SCO 328.6318 shares of its Series A Convertible Preferred
Stock ("Series A Preferred Stock"), initially convertible into 5,477,196 shares
of Common Stock, and warrants to purchase an aggregate of 2,738,598 shares of
Common Stock at an exercise price of $0.75 per share, for aggregate
consideration of $3,286,318 paid by SCO to the Company of which $2,000,000 was
paid in cash and $1,286,318 was paid in the form of cancellation of a Secured
Convertible Promissory Note due August 23, 2006, issued by Somanta in favor of
SCO, as same was amended and restated on November 8, 2005. The warrants expire
six years from the date of issuance. The issuance of these shares of preferred
stock and warrants were exempt from registration under Regulation D promulgated
under the Securities Act or Section 4(2) of the Securities Act. The source of
cash funds for the purchased securities was internal capital of SCO.

In addition, as consideration for services rendered as placement agent in the
Private Placement, SCO Securities received a warrant to purchase 987,720 shares
of Common Stock at an exercise price of $0.60 per share. Other than the exercise
price, the terms of the warrant issued to SCO Securities are the same as the
terms of the warrants issued to the other purchasers in the Private Placement.
The warrants expire six years from the date of issuance. The issuance of these
warrants was exempt from registration under Regulation D promulgated under the
Securities Act or Section 4(2) of the Securities Act. No cash consideration was
paid by SCO Securities to the Company in connection with the issuance of the
placement agent warrants. On February 8, 2006, SCO Securities assigned warrants
to purchase 592,732 of the 987,720 shares to SCO and assigned warrants to
purchase the remaining 394,988 shares to certain employees of SCO and entities
affiliated with such employees.

ITEM 4.  PURPOSE OF TRANSACTION.

Each of the Reporting Persons acquired their shares of Common Stock and
purchased their shares of Series A Preferred Stock and warrants to purchase
Common Stock for investment purposes. Each of the Reporting Persons may acquire
additional shares of Common Stock from time to time, in open market purchases,
negotiated transactions or otherwise, and may sell any or all of such shares of
Common Stock or their shares of Series A Preferred Stock and warrants at any
time.

Other than as set forth in the preceding paragraph of this Item 4, each of the
Reporting Persons does not have any plans or proposals which relate to or would
result in any of the matters enumerated in clauses (a) through (j), inclusive,
of Item 4 of Schedule 13D, namely: (a) the acquisition by any person of
additional securities of the Company or the disposition of securities of the
Company; (b) an extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving the Company or any of its subsidiaries;
(c) a sale or transfer of a material amount of assets of the Company or any of
its subsidiaries; (d) any change in the present Board of Directors or management
of the Company, including any plans or proposals to change the number or term of
directors or to fill any existing vacancies on the Board; (e) any material
change in the present capitalization or dividend policy of the Company; (f) any
other material change in the Company's business or corporate structure; (g)
changes in the Company's charter, bylaws or instruments corresponding thereto or
other actions which may impede the acquisition of control of the Company by any
person; (h) causing a class of securities of the Company to be delisted from a
national securities exchange or to cease to be authorized to be quoted in an
inter-dealer quotation system of a registered national securities association;
(i) a class of equity securities of the Company becoming eligible for
termination of registration pursuant to Section 12(g)(4) of the Exchange Act; or
(j) any action similar to any of those enumerated above.

                                       6



ITEM 5.  INTEREST IN SECURITIES OF THE ISSUER.

(a) This filing relates to 15,887,026 shares of Common Stock held as of the date
hereof as follows: (i) each of the three Trusts owns 353,925 shares of Common
Stock (1,061,775 shares of Common Stock in the aggregate held by the three
Trusts), (ii) SCO owns 6,016,725 shares of Common Stock, 328.6318 shares of
Series A Preferred Stock, which is currently convertible into 5,477,196 shares
of Common Stock, and warrants to purchase an aggregate of 3,331,330 shares of
Common Stock, and (iii) SCO Securities owns no warrants to purchase Common
Stock. These securities in the aggregate represent beneficial ownership of 52.7%
of the outstanding Common Stock of the Company as of January 31, 2006 (as set
forth in its Form 8-K filed on February 6, 2006). In his capacity as Chairman
and sole member of SCO, Mr. Rouhandeh may be deemed beneficially to own (A) the
6,016,725 shares of Common Stock, (B) the 5,477,196 shares of Common Stock
issuable upon conversion of Series A Preferred Stock and (C) the 3,331,330
shares of Common Stock issuable upon exercise of the warrants, in each case,
owned directly by SCO. SCO has provided the Company with notice that it does not
choose to be governed by the ownership limitations provided in Section 5(h) of
the certificate of designations of the Series A Preferred Stock and Section 2.4
of the warrants issued in the Private Placement.

(b) As a trustee of each Trust, Mr. Rouhandeh has shared power with his brother
and spouse to vote the 353,925 shares of Common Stock held by each of the Trusts
(1,061,775 shares of Common Stock in the aggregate held by the three Trusts).
Mr. Rouhandeh, in his capacity as Chairman and sole member of SCO, has the sole
power to direct the vote and disposition of the 6,016,725 shares of Common Stock
owned directly by SCO, the 5,477,196 shares of Common Stock beneficially owned
by SCO upon conversion of Series A Preferred Stock and, upon exercise of
warrants, Mr. Rouhandeh has the sole power to direct the vote and disposition of
an additional 3,331,330 shares of Common Stock underlying warrants owned by SCO.
Mr. Rouhandeh, SCO and SCO Securities disclaim beneficial ownership of the
shares of Common Stock held by the Trusts.

(c) Reference is made to the Reporting Persons' responses to Items 3 and 4.

(d) Not applicable.

(e) Not applicable.

ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER.

Reference is made to the Reporting Persons' responses to Items 3, 4 and 7.


                                        7



ITEM 7.  MATERIAL TO BE FILED AS EXHIBITS.

Exhibit A - Preferred Stock and Warrant Purchase Agreement dated January 31,
            2006 (1)
Exhibit B - Certificate of Designations, Rights and Preferences of the Series A
            Convertible Preferred Stock (1)
Exhibit C - Form of Common Stock Purchase Warrant (1)
Exhibit D - Investor Rights Agreement (1)

(1) Incorporated by reference to Exhibits 3.3, 4.2, 10.17 and 10.18 to the 8-K
of Somanta Pharmaceuticals, Inc. filed February 6, 2006.


                                        8





                                   SIGNATURES

     After reasonable inquiry and to the best of each of our knowledge and
belief, we certify that the information set forth in this statement is true,
complete and correct.

Dated: February 10, 2006

                            SCO CAPITAL PARTNERS LLC


                            By: /s/Steven H. Rouhandeh
                               ----------------------------------
                            Name: Steven H. Rouhandeh
                            Title: Chairman


                            SCO SECURITIES LLC


                            By: /s/Jeffrey B. Davis
                               ----------------------------------
                            Name: Jeffrey B. Davis
                            Title: President




                            /s/Steven H. Rouhandeh
                            ----------------------------------
                               Steven H. Rouhandeh



                                       9